Übersetzung
EnglishDeutsch
Als Standard-Sprache

Central Banks May be Enabling Unhealthy Corporate Buyouts – Pia Rennert & Gunther Schnabl (04/23/2019)

23. April, 2019 | Mit brinvest | Kategorie: WallStreetWindow

German pharma giant Bayer’s acquisition of Monsanto is only one prominent case of leveraged buyouts (LBOs), which have been flourishing since the 1990s (see Figure). After Bayer has paid 66 billion dollars for Monsanto, the stock value of the merged enterprise has collapsed below Bayer’s pre-merger value. Bayer faces more than 10,000 US lawsuits over

The post Central Banks May be Enabling Unhealthy Corporate BuyoutsPia Rennert & Gunther Schnabl (04/23/2019) appeared first on WallStreetWindow.com.

Dieser Beitrag ist syndizierte, Original-Artikel lesen.